Gene: PHOSPHO2
Official Full Name: phosphatase, orphan 2provided by HGNC
Gene Summary: Predicted to enable phosphatase activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15171 | PHOSPHO2 Knockout cell line (HeLa) | Human | PHOSPHO2 | 1:3~1:6 | Negative | Online Inquiry |
KO15172 | PHOSPHO2 Knockout cell line (HCT 116) | Human | PHOSPHO2 | 1:2~1:4 | Negative | Online Inquiry |
KO15173 | PHOSPHO2 Knockout cell line (HEK293) | Human | PHOSPHO2 | 1:3~1:6 | Negative | Online Inquiry |
KO15174 | PHOSPHO2 Knockout cell line (A549) | Human | PHOSPHO2 | 1:3~1:4 | Negative | Online Inquiry |
PHOSPHO2 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the biological functions of the PHOSPHO2 gene by eliminating its expression. This innovative product leverages CRISPR-Cas9 technology to create precise gene knockouts, allowing researchers to investigate the role of PHOSPHO2 in various cellular processes such as signal transduction, cell differentiation, and apoptosis. By disrupting the PHOSPHO2 gene, these cell lines enable the elucidation of its contributions to health and disease, thereby serving as crucial tools in functional genomics and molecular biology research.
The PHOSPHO2 Gene Knockout Cell Lines provide scientists with a robust mechanism to study the ramifications of PHOSPHO2 deletion on cellular pathways. Through loss-of-function studies, researchers can assess alterations in metabolic profiles, gene expression patterns, and protein interactions, making these cell lines invaluable in understanding the mechanisms underlying various pathologies, including cancer and metabolic disorders. The ability to scrutinize these specific cellular changes in controlled laboratory settings facilitates the discovery of novel therapeutic targets.
Compared to existing alternatives, such as traditional knockdown methods using siRNA or shRNA, PHOSPHO2 Gene Knockout Cell Lines offer distinct advantages in specificity and permanency. The CRISPR-Cas9 system not only provides a more stable alteration of the genome but also obviates off-target effects, ensuring that researchers can derive accurate conclusions from their experiments. Additionally, these cell lines are designed for easy adaptability across various platforms, whether for high-throughput screening or in-depth mechanistic studies.
For researchers and clinicians focused on genetics, cell biology, or drug discovery, PHOSPHO2 Gene Knockout Cell Lines represent a high-value asset that unlocks a deeper understanding of gene function. Our commitment to advancing scientific knowledge through cutting-edge technology and our expertise in genetic engineering empower us to provide top-tier biological products that meet the evolving demands of modern research environments.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.